RESOLVE: Abemaciclib + Letrozole +/- Metformin, Zotatifin, or Gedatolisib in Endometrial or Low-Grade Serous Ovarian Cancer

NCT03675893 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

180

Enrollment

OTHER

Sponsor class

Conditions

Endometrial Cancer
Ovarian Cancer

Interventions

DRUG: Letrozole
DRUG: Abemaciclib
DRUG: LY3023414
DRUG: Metformin
DRUG: Zotatifin
DRUG: Gedatolisib

Sponsor

Dana-Farber Cancer Institute

Collaborators

[object Object]
[object Object]
[object Object]